Cargando…

Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization

BACKGROUND: Before the coronavirus disease 2019 (COVID-19) vaccine release, polls showed only 50% of Americans had intention to receive the COVID-19 vaccine. The vaccine hesitancy may result from a lack of confidence in vaccine safety and efficacy. More research is needed to identify whether knowled...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmosino, Elizabeth, Ruisinger, Janelle F., Kinsey, Joshua Davis, Melton, Brittany L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733284/
https://www.ncbi.nlm.nih.gov/pubmed/35065886
http://dx.doi.org/10.1016/j.japh.2022.01.001
_version_ 1784627769422905344
author Carmosino, Elizabeth
Ruisinger, Janelle F.
Kinsey, Joshua Davis
Melton, Brittany L.
author_facet Carmosino, Elizabeth
Ruisinger, Janelle F.
Kinsey, Joshua Davis
Melton, Brittany L.
author_sort Carmosino, Elizabeth
collection PubMed
description BACKGROUND: Before the coronavirus disease 2019 (COVID-19) vaccine release, polls showed only 50% of Americans had intention to receive the COVID-19 vaccine. The vaccine hesitancy may result from a lack of confidence in vaccine safety and efficacy. More research is needed to identify whether knowledge of vaccine approval processes relates to vaccination intentions. OBJECTIVES: The objectives of this study were to (1) evaluate participants’ knowledge regarding COVID-19 and vaccine approval processes, (2) evaluate participants’ intentions to receive the COVID-19 vaccine, and (3) compare participants’ knowledge assessment results with COVID-19 vaccine intentions. METHODS: A prospective, cross-sectional questionnaire was administered to patients participating in a pharmacist-led chronic disease state management program. The 22-item questionnaire assessed demographic information and evaluated the participant’s knowledge and vaccine intentions. Data were analyzed with an a priori alpha value of 0.05. RESULTS: Nearly all participants answered correctly on questions pertaining to COVID-19 infection (n = 92, 93%), COVID-19 symptoms (n = 96, 96%), and the Food and Drug Administration’s roles in vaccine approval processes (n = 92, 92%). Participants scored lower on questions involving the differing requirements between clinical trial phases (n = 20, 21%) and vaccine safety in the United States (n = 51, 53%). Most participants (n = 54, 55.1%) did not believe the trials were taking too long to produce a vaccine, but 40.4% of the participants (n = 40) believed the vaccine was approved too quickly. More than half of the participants (n = 55, 56.1%) desired more information on how vaccines get approved in the United States. Participants who scored higher on the knowledge assessment were more likely to have a plan to receive the vaccine (P = 0.008). CONCLUSIONS: The results of this study demonstrate the influence knowledge has on intentions to receive vaccines and may aid health care providers in their attempts to promote vaccinations.
format Online
Article
Text
id pubmed-8733284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Pharmacists Association®. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-87332842022-01-06 Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization Carmosino, Elizabeth Ruisinger, Janelle F. Kinsey, Joshua Davis Melton, Brittany L. J Am Pharm Assoc (2003) Science and Practice BACKGROUND: Before the coronavirus disease 2019 (COVID-19) vaccine release, polls showed only 50% of Americans had intention to receive the COVID-19 vaccine. The vaccine hesitancy may result from a lack of confidence in vaccine safety and efficacy. More research is needed to identify whether knowledge of vaccine approval processes relates to vaccination intentions. OBJECTIVES: The objectives of this study were to (1) evaluate participants’ knowledge regarding COVID-19 and vaccine approval processes, (2) evaluate participants’ intentions to receive the COVID-19 vaccine, and (3) compare participants’ knowledge assessment results with COVID-19 vaccine intentions. METHODS: A prospective, cross-sectional questionnaire was administered to patients participating in a pharmacist-led chronic disease state management program. The 22-item questionnaire assessed demographic information and evaluated the participant’s knowledge and vaccine intentions. Data were analyzed with an a priori alpha value of 0.05. RESULTS: Nearly all participants answered correctly on questions pertaining to COVID-19 infection (n = 92, 93%), COVID-19 symptoms (n = 96, 96%), and the Food and Drug Administration’s roles in vaccine approval processes (n = 92, 92%). Participants scored lower on questions involving the differing requirements between clinical trial phases (n = 20, 21%) and vaccine safety in the United States (n = 51, 53%). Most participants (n = 54, 55.1%) did not believe the trials were taking too long to produce a vaccine, but 40.4% of the participants (n = 40) believed the vaccine was approved too quickly. More than half of the participants (n = 55, 56.1%) desired more information on how vaccines get approved in the United States. Participants who scored higher on the knowledge assessment were more likely to have a plan to receive the vaccine (P = 0.008). CONCLUSIONS: The results of this study demonstrate the influence knowledge has on intentions to receive vaccines and may aid health care providers in their attempts to promote vaccinations. American Pharmacists Association®. Published by Elsevier Inc. 2022 2022-01-06 /pmc/articles/PMC8733284/ /pubmed/35065886 http://dx.doi.org/10.1016/j.japh.2022.01.001 Text en © 2022 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Science and Practice
Carmosino, Elizabeth
Ruisinger, Janelle F.
Kinsey, Joshua Davis
Melton, Brittany L.
Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization
title Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization
title_full Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization
title_fullStr Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization
title_full_unstemmed Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization
title_short Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization
title_sort vaccination approval literacy and its effects on intention to receive future covid-19 immunization
topic Science and Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733284/
https://www.ncbi.nlm.nih.gov/pubmed/35065886
http://dx.doi.org/10.1016/j.japh.2022.01.001
work_keys_str_mv AT carmosinoelizabeth vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization
AT ruisingerjanellef vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization
AT kinseyjoshuadavis vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization
AT meltonbrittanyl vaccinationapprovalliteracyanditseffectsonintentiontoreceivefuturecovid19immunization